Form 8-K - Current report:
SEC Accession No. 0000950170-21-001776
Filing Date
2021-09-13
Accepted
2021-09-13 08:14:45
Documents
15
Period of Report
2021-09-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20210913.htm   iXBRL 8-K 60673
2 EX-99.1 acet-20210913ex99_1.htm EX-99.1 22459
3 GRAPHIC img44277468_1.jpg GRAPHIC 14303
4 GRAPHIC img44277468_0.jpg GRAPHIC 20194
  Complete submission text file 0000950170-21-001776.txt   267629

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20210913_pre.xml EX-101.PRE 11504
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20210913_lab.xml EX-101.LAB 19138
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20210913.xsd EX-101.SCH 2495
8 EXTRACTED XBRL INSTANCE DOCUMENT acet-20210913_htm.xml XML 4877
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 211248682
SIC: 2834 Pharmaceutical Preparations